These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9005879)

  • 1. Trihexyphenidyl withdrawal encephalopathy.
    Johkura K; Matsumoto S; Hasegawa O; Kuroiwa Y
    Ann Neurol; 1997 Jan; 41(1):133-4. PubMed ID: 9005879
    [No Abstract]   [Full Text] [Related]  

  • 2. Life-threatening cranial dystonia following trihexyphenidyl withdrawal.
    Giménez-Roldán S; Mateo D; Martín M
    Mov Disord; 1989; 4(4):349-53. PubMed ID: 2811895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcoholism and disruption of the activity of deep cerebral structures. Clinical-laboratory research.
    Segal BM; Kushnarev VM; Urakov IG; Misionzhnik EU
    Q J Stud Alcohol; 1970 Sep; 31(3):587-601. PubMed ID: 5458470
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid withdrawal results in an increased local and remote functional connectivity at EEG alpha and beta frequency bands.
    Fingelkurts AA; Fingelkurts AA; Kivisaari R; Autti T; Borisov S; Puuskari V; Jokela O; Kähkönen S
    Neurosci Res; 2007 May; 58(1):40-9. PubMed ID: 17320230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal of trihexyphenidyl.
    McInnis M; Petursson H
    Acta Psychiatr Scand; 1985 Mar; 71(3):297-303. PubMed ID: 3984771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myoclonic encephalopathy caused by lead intoxication].
    Vivancos Matellano FV; Caminero AB; Frank A; Díez Tejedor E; Barreiro P
    Neurologia; 1993; 8(6):205-6. PubMed ID: 8352979
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear magnetic resonance observations in alcoholic cerebral disorder and the role of vasopressin.
    Besson JA; Glen AI; Foreman EI; MacDonald A; Smith FW; Hutchison JM; Mallard JR; Ashcroft GW
    Lancet; 1981 Oct; 2(8252):923-4. PubMed ID: 6117697
    [No Abstract]   [Full Text] [Related]  

  • 8. [Does a specific withdrawal syndrome from non-dopaminergic antiparkinson agents exist?].
    George V; Castot A; Bidault I
    Therapie; 1987; 42(4):339-41. PubMed ID: 3686467
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcranial microelectrostimulation activates fast mechanisms of brain plasticity.
    Kharchenko EV
    Dokl Biol Sci; 2001; 378():217-9. PubMed ID: 12918332
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate-induced encephalopathy.
    Rehman A; Zafar S
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trihexyphenidyl dependence.
    McInnis M; Petursson H
    Acta Psychiatr Scand; 1984 Jun; 69(6):538-42. PubMed ID: 6741602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reorganization of the composition of brain oscillations and their temporal characteristics during opioid withdrawal.
    Fingelkurts A; Kähkönen S; Fingelkurts A; Kivisaari R; Borisov S; Puuskari V; Jokela O; Autti T
    J Psychopharmacol; 2008 May; 22(3):270-84. PubMed ID: 18541625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The thyreotoxic encephalopathy].
    Kollmannsberger A; Kugler J; Schwarz K; Scriba PC
    Rev Neurol (Paris); 1967 Jul; 117(1):124-8. PubMed ID: 6063846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and physiopathological study of hepatic encephalopathy].
    Spatz R; Kollmannsberger AM
    Cah Med; 1972 May; 13(6):429-34. PubMed ID: 5070689
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminophylline encephalopathy: a clinical, electroencephalographic, and neuropathological analysis.
    Culberson CG; Langston JW; Herrick M
    Trans Am Neurol Assoc; 1979; 104():224-6. PubMed ID: 553417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interhemispheric relationships in opiate-addicted patients during the withdrawal and early post-withdrawal periods].
    Aleksandrov SG
    Fiziol Cheloveka; 2004; 30(4):40-5. PubMed ID: 15495522
    [No Abstract]   [Full Text] [Related]  

  • 17. Primidone-induced hyperammonemic encephalopathy in a patient with cerebral astrocytoma.
    Katano H; Fukushima T; Karasawa K; Sugiyama N; Ohkura A; Kamiya K
    J Clin Neurosci; 2002 Jan; 9(1):79-81. PubMed ID: 11749025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and electroencephalographic correlates in bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Jouglard J
    Therapie; 1980; 35(3):293-6. PubMed ID: 7423414
    [No Abstract]   [Full Text] [Related]  

  • 19. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome.
    Kozak OS; Wijdicks EF; Manno EM; Miley JT; Rabinstein AA
    Neurology; 2007 Aug; 69(9):894-7. PubMed ID: 17724292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hashimoto encephalopathy in a 15-year-old-girl: EEG findings and follow-up.
    Muhle H; van Baalen A; Riepe FG; Rohr A; Stephani U
    Pediatr Neurol; 2009 Oct; 41(4):301-4. PubMed ID: 19748053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.